Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Development and validation of the Nancy histological index for UC
2015 Standout
Management of hepatitis B
2007
Microbiota in health and diseases
2022 Standout
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Systemic and topical steroids in inflammatory bowel disease
2004
Review article: hepatitis B and liver transplantation
2006
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Functional Bowel Disorders
2006 Standout
Management of Crohn's disease in adults
2001
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
1993 Standout
No Benefit of Hemodiafiltration over Hemodialysis in Lowering Elevated Levels of Asymmetric Dimethylarginine in ESRD Patients
2006
Pancreatic cancer
2020 Standout
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Screening for pancreatic cancer in familial high-risk individuals: A systematic review
2015
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis
2005
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease
2000
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
A randomized controlled trial of lamivudine to treat acute hepatitis B
2006
Genetic Polymorphisms of HumanN-Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity
1999
Crohn's disease
2012 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Hepatitis B virus infection
2009 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Antecedent liver disease and drug toxicity
1999
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches
2015
Partial fatty acid oxidation inhibitors for stable angina
2002
Crohn's disease
2016 Standout
Endosonography with linear array instead of endoscopic retrograde cholangiography as the diagnostic tool in patients with moderate suspicion of common bile duct stones
2003
Probiotics and clinical effects: is the number what counts?
2013
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Microfluidic organs-on-chips
2014 Standout
Chronic hepatitis B
2007 Standout
New pathophysiological insights and modern treatment of IBD
2010
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Chronic hepatitis B: Update 2009 #
2009 Standout
Role of the gut microbiota in nutrition and health
2018 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Ulcerative colitis
2016 Standout
A Myriad of Pathways to NASH
2012
Idiosyncratic drug hepatotoxicity
2005
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
2012
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
1989
The global NAFLD epidemic
2013 Standout
Drug metabolism and hepatotoxicity.
1991
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Histopathologic analysis of suspected amiodarone hepatotoxicity
1990
Oral budesonide in the treatment of primary sclerosing cholangitis
2000
Ulcerative colitis
2020 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Practice Guidelines in Acute Pancreatitis
2006 Standout
Prebiotics in Chronic Intestinal Inflammation
2009
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
2006
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
2014
Cancer-related inflammation
2008 StandoutNature
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate
2016
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era
2009
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
2009
Treatment with lamivudine and entecavir in severe acute hepatitis B
2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Constipation:
2003
State of the Art: Ibd Therapy and Clinical Trials in Ibd
2005
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
2009 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Recent advances in Sonogashira reactions
2011 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions
1994
Probiotics: sorting the evidence from the myths
2008
Gut Microbiota in Health and Disease
2010 Standout
Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
2015
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study
2002
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.
1996
Functional Oligosaccharides: Application and Manufacture
2010
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
DRUG METABOLISM BY CYTOCHROMES P450 IN THE LIVER AND SMALL BOWEL
1992
Palladium‐mediated synthesis of novel nimesulide derivatives
2010
Causes, relevant mechanisms, and prevention of large bowel cancer.
1991
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
1994
Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis
2014
Budesonide for induction of remission in Crohn's disease
2015
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double‐blinded multicentre trial
2013
Synbiotics in Health and Disease
2011
Drug-induced liver disease
2000
Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom
2010
The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials
2015
Metabolic Modulation With Perhexiline in Chronic Heart Failure
2005
Synbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities
2018
Works of Ron Reshef being referenced
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
1984
Immunohistochemical detection of p53 protein expression in HPV-induced condyloma acuminatum.
1995
Lamivudine treatment for acute severe hepatitis B: a pilot study
2004
The Impact of Endoscopic Ultrasonography on the Management of Suspected Pancreatic Cancer-A Comprehensive Longitudinal Continuous Evaluation
2007
Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn’s Disease
2007
Linear EUS for bile duct stones
2000
Colon cancer bearing rats produce a lymphokine which induces Macrophage Migration Inhibition (MIF) in vitro
1988
Budesonide versus prednisone in the treatment of active Crohn's disease
1998
Nimesulide-Induced Acute Hepatitis
2001
The macrophage migration inhibition (MIF) assay as a marker of colorectal cancer
1987
Effect of a calcium-enriched diet on the colonic epithelial hyperproliferation induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats on a low calcium and fat diet.
1990
Systemic effects of rectally administered corticosteroids.
1992